Lake Street Maintains Buy on Rezolute, Raises Price Target to $12

10/6/2026
Impact: 75
Healthcare

Lake Street analyst Daniel Brims has maintained a Buy rating on Rezolute (NASDAQ: RZLT) and raised the price target from $9 to $12. This adjustment reflects a positive outlook for the company in the market.

AI summary, not financial advice

Share: